These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 22065755)

  • 1. α-Synuclein fate is determined by USP9X-regulated monoubiquitination.
    Rott R; Szargel R; Haskin J; Bandopadhyay R; Lees AJ; Shani V; Engelender S
    Proc Natl Acad Sci U S A; 2011 Nov; 108(46):18666-71. PubMed ID: 22065755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease.
    Engelender S
    Autophagy; 2008 Apr; 4(3):372-4. PubMed ID: 18216494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein fate: proteasome or autophagy?
    Engelender S
    Autophagy; 2012 Mar; 8(3):418-20. PubMed ID: 22361583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synphilin-1A inhibits seven in absentia homolog (SIAH) and modulates alpha-synuclein monoubiquitylation and inclusion formation.
    Szargel R; Rott R; Eyal A; Haskin J; Shani V; Balan L; Wolosker H; Engelender S
    J Biol Chem; 2009 Apr; 284(17):11706-16. PubMed ID: 19224863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease.
    Alexopoulou Z; Lang J; Perrett RM; Elschami M; Hurry ME; Kim HT; Mazaraki D; Szabo A; Kessler BM; Goldberg AL; Ansorge O; Fulga TA; Tofaris GK
    Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4688-97. PubMed ID: 27444016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells.
    Rott R; Szargel R; Haskin J; Shani V; Shainskaya A; Manov I; Liani E; Avraham E; Engelender S
    J Biol Chem; 2008 Feb; 283(6):3316-3328. PubMed ID: 18070888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitylation of synphilin-1 and alpha-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease.
    Liani E; Eyal A; Avraham E; Shemer R; Szargel R; Berg D; Bornemann A; Riess O; Ross CA; Rott R; Engelender S
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5500-5. PubMed ID: 15064394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions.
    Shahpasandzadeh H; Popova B; Kleinknecht A; Fraser PE; Outeiro TF; Braus GH
    J Biol Chem; 2014 Nov; 289(45):31224-40. PubMed ID: 25231978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
    Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
    Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death.
    Lee JT; Wheeler TC; Li L; Chin LS
    Hum Mol Genet; 2008 Mar; 17(6):906-17. PubMed ID: 18065497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.
    Poehler AM; Xiang W; Spitzer P; May VE; Meixner H; Rockenstein E; Chutna O; Outeiro TF; Winkler J; Masliah E; Klucken J
    Autophagy; 2014; 10(12):2171-92. PubMed ID: 25484190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase 3beta modulates synphilin-1 ubiquitylation and cellular inclusion formation by SIAH: implications for proteasomal function and Lewy body formation.
    Avraham E; Szargel R; Eyal A; Rott R; Engelender S
    J Biol Chem; 2005 Dec; 280(52):42877-86. PubMed ID: 16174773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
    Tofaris GK; Razzaq A; Ghetti B; Lilley KS; Spillantini MG
    J Biol Chem; 2003 Nov; 278(45):44405-11. PubMed ID: 12923179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein/phospholipase C (PLCbeta1) interactions.
    Dalfó E; Albasanz JL; Martin M; Ferrer I
    Brain Pathol; 2004 Oct; 14(4):388-98. PubMed ID: 15605986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific differences in proteasome-dependent degradation of monoubiquitinated α-synuclein.
    Abeywardana T; Lin YH; Rott R; Engelender S; Pratt MR
    Chem Biol; 2013 Oct; 20(10):1207-13. PubMed ID: 24210006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein aggregation involves a bafilomycin A 1-sensitive autophagy pathway.
    Klucken J; Poehler AM; Ebrahimi-Fakhari D; Schneider J; Nuber S; Rockenstein E; Schlötzer-Schrehardt U; Hyman BT; McLean PJ; Masliah E; Winkler J
    Autophagy; 2012 May; 8(5):754-66. PubMed ID: 22647715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation.
    Kim YM; Jang WH; Quezado MM; Oh Y; Chung KC; Junn E; Mouradian MM
    J Neurol Sci; 2011 Aug; 307(1-2):157-61. PubMed ID: 21641618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.
    Tanik SA; Schultheiss CE; Volpicelli-Daley LA; Brunden KR; Lee VM
    J Biol Chem; 2013 May; 288(21):15194-210. PubMed ID: 23532841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Protein Ubiquitination by Paraquat and 1-Methyl-4-Phenylpyridinium Impairs Ubiquitin-Dependent Protein Degradation Pathways.
    Navarro-Yepes J; Anandhan A; Bradley E; Bohovych I; Yarabe B; de Jong A; Ovaa H; Zhou Y; Khalimonchuk O; Quintanilla-Vega B; Franco R
    Mol Neurobiol; 2016 Oct; 53(8):5229-51. PubMed ID: 26409479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.